United States Software as a Medical Devices Market 2026 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

he global healthcare industry is undergoing a significant transformation as digital technologies become increasingly integrated into clinical workflows and patient care management. Among these innovations, Software as a Medical Device (SaMD) is emerging as a critical component of modern healthcare systems, enabling advanced diagnostics, remote monitoring, and data-driven clinical decision support. Software as a medical devices (SaMD) market is estimated to reach at a CAGR of 69.31% during the forecast period (2024-2031).

Request Executive Sample:- https://www.datamintelligence.com/download-sample/software-as-a-medical-devices-market?sb

Key Development:

United States: Recent Industry Developments

✅ In March 2026, Viz.ai received U.S. FDA clearance for an expanded version of its AI-powered clinical decision support software designed to detect cardiovascular conditions from medical imaging. The software helps clinicians rapidly identify life-threatening abnormalities and streamline treatment workflows. The approval strengthens the adoption of AI-driven Software as a Medical Device solutions in hospitals.

✅ In February 2026, GE HealthCare launched an advanced AI-enabled digital platform designed to support Software as a Medical Device applications for diagnostic imaging and clinical workflow optimization. The platform integrates cloud-based analytics and real-time clinical insights. It enhances efficiency and decision-making across radiology and hospital care environments.

✅ In January 2026, Medtronic announced the acquisition of a digital health startup specializing in AI-based Software as a Medical Device solutions for chronic disease monitoring. The acquisition expands Medtronic's portfolio of remote patient monitoring and digital therapeutics technologies. It accelerates development of data-driven clinical decision support tools.

✅ In January 2026, Google Health introduced new generative AI capabilities integrated into medical software platforms used for diagnostics and clinical documentation. The technology supports automated analysis of medical data and improved patient care workflows. It advances the role of AI-powered software platforms in regulated medical environments.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=software-as-a-medical-devices-market

Japan: Recent Industry Developments

✅ In March 2026, Fujifilm launched an AI-based medical imaging analysis software designed to support early disease detection in radiology workflows. The platform integrates advanced algorithms to assist clinicians in identifying abnormalities with improved accuracy. It strengthens Japan's innovation in Software as a Medical Device solutions for diagnostic healthcare.

✅ In February 2026, Canon Medical Systems introduced a cloud-based clinical decision support platform using AI algorithms to assist in diagnostic imaging interpretation. The system enables hospitals to deploy Software as a Medical Device applications across connected healthcare networks. It improves diagnostic speed and clinical efficiency.

✅ In January 2026, Sony Group invested in a digital health startup focused on AI-driven medical software for remote diagnostics and patient monitoring. The investment supports development of scalable Software as a Medical Device platforms for telehealth and digital care delivery. It expands Japan's growing ecosystem for AI healthcare innovation.

✅ In January 2026, NEC Corporation launched an AI-enabled clinical data analytics platform designed to support predictive healthcare and digital diagnostics. The platform processes large medical datasets to generate clinical insights and early disease detection signals. It advances Japan's adoption of regulated AI software solutions in healthcare systems.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/software-as-a-medical-devices-market?sb

Rising Adoption of AI-Powered Clinical Decision Support Systems

One of the major growth drivers for the Software as a Medical Devices market is the rapid adoption of artificial intelligence-based clinical decision support systems. AI-enabled SaMD platforms can analyze large volumes of medical data, including imaging scans, laboratory reports, and electronic health records, to assist physicians in making accurate and timely diagnoses.

Machine learning algorithms are increasingly used to detect abnormalities in medical images, predict disease progression, and identify personalized treatment pathways for patients. These capabilities are significantly improving diagnostic accuracy in fields such as radiology, cardiology, oncology, and neurology.

Healthcare providers are increasingly deploying AI-driven software solutions to enhance clinical workflows and reduce the burden on healthcare professionals. By automating complex data analysis and providing real-time insights, SaMD platforms help clinicians focus more on patient care while improving overall treatment outcomes.

The United States, Europe, Japan, and South Korea are among the leading regions driving the adoption of AI-enabled Software as a Medical Devices solutions. These regions are investing heavily in digital healthcare infrastructure and regulatory frameworks that support the development and commercialization of advanced medical software technologies.

Expanding Role in Remote Patient Monitoring and Telehealth

Remote patient monitoring and telehealth services are rapidly becoming central components of modern healthcare systems. Software as a Medical Devices solutions play a vital role in enabling continuous monitoring of patients with chronic conditions such as diabetes, cardiovascular diseases, respiratory disorders, and neurological conditions.

SaMD applications integrated with wearable devices and mobile health platforms allow healthcare providers to collect real-time patient data, track vital signs, and detect early warning signs of disease progression. These solutions significantly reduce hospital visits while enabling proactive disease management and improved patient outcomes.

During the global expansion of telemedicine services, SaMD platforms have become essential tools for delivering virtual healthcare services. Physicians can remotely monitor patients, analyze clinical data, and adjust treatment plans without requiring in-person consultations.

As healthcare systems increasingly focus on preventive care and chronic disease management, the demand for advanced remote monitoring software solutions is expected to grow significantly.

Competitive Landscape and Industry Leadership

The global Software as a Medical Devices market is highly competitive, with several technology companies, medical device manufacturers, and digital health startups developing innovative medical software solutions. Leading companies operating in the market include: Arterys Inc., Paragon Biosciences (Qlarity Imaging LLC), Viz.ai, Inc., VitalConnect., Apple, Inc., iSchemaView, inc. (RAPID), IDx Technologies Inc., MaxQ AI, Ltd. Greenfinch Technology, Siemens Healthineers AG, and Koninklijke Philips N.V.

Key Segments:

By Device Type

Smartphones/Tablets dominate with 45% share, driven by the widespread use of mobile health applications, remote patient monitoring tools, and easy accessibility for healthcare providers and patients. Wearable Devices account for 30%, supported by the growing adoption of fitness trackers, smartwatches, and health-monitoring wearables for continuous data tracking and preventive healthcare. PCs/Laptops hold 25%, fueled by their use in hospitals, diagnostic centers, and clinical environments for data analysis, patient management, and medical software platforms.

By Application

Clinical Management leads with 60% share, driven by increasing demand for digital healthcare platforms that support patient monitoring, treatment planning, and chronic disease management. Diagnostic Applications account for 40%, supported by the rising adoption of digital diagnostic tools, AI-powered imaging systems, and advanced data analytics for early disease detection and accurate diagnosis.

By Deployment Method

Cloud-Based Deployment dominates with 65% share, fueled by advantages such as scalability, remote accessibility, cost efficiency, and seamless data integration across healthcare systems. On-Premise Deployment represents 35%, supported by healthcare institutions that prioritize data security, regulatory compliance, and internal infrastructure control.

By Region

North America - 35% Share
North America leads with 35%, driven by advanced healthcare infrastructure, strong adoption of digital health technologies, and increasing investments in remote patient monitoring and telehealth solutions in the U.S. and Canada.

Europe - 25% Share
Europe holds 25%, supported by government initiatives promoting digital healthcare transformation and growing adoption of healthcare IT systems across Germany, the U.K., France, and other countries.

Asia Pacific - 25% Share
Asia Pacific accounts for 25%, fueled by expanding healthcare infrastructure, rising smartphone penetration, and increasing investments in digital health technologies in countries such as China, India, Japan, and South Korea.

Middle East & Africa - 10% Share
The Middle East & Africa represent 10%, driven by improving healthcare infrastructure, government digital health initiatives, and rising adoption of telemedicine platforms.

South America - 5% Share
South America holds 5%, supported by growing healthcare digitalization efforts, increasing mobile health adoption, and expanding healthcare services in countries such as Brazil and Argentina.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.